Abstract
BACKGROUND: Several gene-expression signatures can be used to predict the prognosis in diffuse large-B-cell lymphoma, but the lack of practical tests for a genome-scale analysis has restricted the use of this method. METHODS: We studied 36 genes whose expression had been reported to predict survival in diffuse large-B-cell lymphoma. We measured the expression of each of these genes in independent samples of lymphoma from 66 patients by quantitative real-time polymerase-chain-reaction analyses and related the results to overall survival. RESULTS: In a univariate analysis, genes were ranked on the basis of their ability to predict survival. The genes that were the strongest predictors were LMO2, BCL6, FN1, CCND2, SCYA3, and BCL2. We developed a multivariate model that was based on the expression of these six genes, and we validated the model in two independent microarray data sets. The model was independent of the International Prognostic Index and added to its predictive power. CONCLUSIONS: Measurement of the expression of six genes is sufficient to predict overall survival in diffuse large-B-cell lymphoma.
| Original language | English |
|---|---|
| Pages (from-to) | 1828-1837 |
| Number of pages | 10 |
| Journal | New England Journal of Medicine |
| Volume | 350 |
| Issue number | 18 |
| DOIs | |
| State | Published - Apr 29 2004 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. / Lossos, Izidore; Czerwinski, Debra K.; Alizadeh, Ash A.; Wechser, Mark A.; Tibshirani, Rob; Botstein, David; Levy, Ronald.
In: New England Journal of Medicine, Vol. 350, No. 18, 29.04.2004, p. 1828-1837.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes
AU - Lossos, Izidore
AU - Czerwinski, Debra K.
AU - Alizadeh, Ash A.
AU - Wechser, Mark A.
AU - Tibshirani, Rob
AU - Botstein, David
AU - Levy, Ronald
PY - 2004/4/29
Y1 - 2004/4/29
N2 - BACKGROUND: Several gene-expression signatures can be used to predict the prognosis in diffuse large-B-cell lymphoma, but the lack of practical tests for a genome-scale analysis has restricted the use of this method. METHODS: We studied 36 genes whose expression had been reported to predict survival in diffuse large-B-cell lymphoma. We measured the expression of each of these genes in independent samples of lymphoma from 66 patients by quantitative real-time polymerase-chain-reaction analyses and related the results to overall survival. RESULTS: In a univariate analysis, genes were ranked on the basis of their ability to predict survival. The genes that were the strongest predictors were LMO2, BCL6, FN1, CCND2, SCYA3, and BCL2. We developed a multivariate model that was based on the expression of these six genes, and we validated the model in two independent microarray data sets. The model was independent of the International Prognostic Index and added to its predictive power. CONCLUSIONS: Measurement of the expression of six genes is sufficient to predict overall survival in diffuse large-B-cell lymphoma.
AB - BACKGROUND: Several gene-expression signatures can be used to predict the prognosis in diffuse large-B-cell lymphoma, but the lack of practical tests for a genome-scale analysis has restricted the use of this method. METHODS: We studied 36 genes whose expression had been reported to predict survival in diffuse large-B-cell lymphoma. We measured the expression of each of these genes in independent samples of lymphoma from 66 patients by quantitative real-time polymerase-chain-reaction analyses and related the results to overall survival. RESULTS: In a univariate analysis, genes were ranked on the basis of their ability to predict survival. The genes that were the strongest predictors were LMO2, BCL6, FN1, CCND2, SCYA3, and BCL2. We developed a multivariate model that was based on the expression of these six genes, and we validated the model in two independent microarray data sets. The model was independent of the International Prognostic Index and added to its predictive power. CONCLUSIONS: Measurement of the expression of six genes is sufficient to predict overall survival in diffuse large-B-cell lymphoma.
UR - http://www.scopus.com/inward/record.url?scp=2342587416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2342587416&partnerID=8YFLogxK
U2 - 10.1056/NEJMoa032520
DO - 10.1056/NEJMoa032520
M3 - Article
C2 - 15115829
AN - SCOPUS:2342587416
VL - 350
SP - 1828
EP - 1837
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 18
ER -